Inhibitory effect of a new ureidophenol derivative T-2591 on LDL oxidation and ACAT activity

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 10, 1997, Pages 1056-1060

  Yasuhara, Mikiko ^a   Saito, Keiko ^a   Kubota, Hitoshi ^a   Ohmizu, Hiroshi ^a   Suzuki, Toshikazu ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Acyl CoA; Antioxidant; Cholesterol acyltransferase; Low density lipoprotein; Macrophage; T 2591

Indexed keywords

1 (3 TERT BUTYL 2 HYDROXY 5 METHOXYPHENYL) 3 (2 CYCLOHEXYLETHYL) 3 (4 DIMETHYLAMINOPHENYL)UREA; 2,2 DIMETHYL N (2,4,6 TRIMETHOXYPHENYL)DODECANAMIDE; CARBANILAMIDE DERIVATIVE; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; COPPER ION; LOW DENSITY LIPOPROTEIN; PROBUCOL; T 2591; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; ATHEROSCLEROSIS; CATTLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; FOAM CELL; HUMAN; INTESTINE; LIPOPROTEIN METABOLISM; LIVER; MACROPHAGE; MALE; MOUSE; NONHUMAN; RABBIT;

EID: 0030715610     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.1056     Document Type: Article

References (43)

1. Fowler S., Shio H., Haley N. J., Lab. Invest., 41, 372-378 (1979).
2. Gerrity R. G., Am. J. Pathol., 103, 181-190 (1981).
3. Gerrity R. G., Am. J. Pathol., 103, 191-200 (1981).
4. Aqel N. M., Ball R. Y., Waldman H., Mitchinson M. J., Atherosclerosis. 53, 265-271 (1984).
5. Rosenfeld M. E., Tsukada T., Gown A. M., Ross R., Arteriosclerosis. 1, 9-23 (1987).
6. Shaikh M., Martini S., Quiney J. R., Baskerville P., La Ville A. E., Browse N.L., Duffield R., Turner P. R., Lewis B., Atherosclerosis, 69, 165-172 (1988).
7. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L., New Engl. J. Med., 320, 915- 924 (1989).
8. Henriksen T., Mahoney R. M., Steinberg D., Proc. Natl. Acad. Sci. U.S.A., 78, 6499-6503 (1981).
9. Aviram M., Rosenblat M., J. Lipid Res., 35, 385-398 (1994).
10. Li Q., Cathcart M. K., J Biol. Chem., 269, 17508-17515 (1994).
11. Heinecke J. W., Baker L., Roasen H., Chait A., J. Clin. Invest., 77, 757-761 (1986).
12. Hurt-Camejo E., Camejo G., Rosengren B., Lopez F., Ahlstrom C. Fager G., Bondjers G., Arteriosclerosis, 12, 569-579 (1992).
13. Brown M. S., Goldstein J. L., Annu. Rev. Biochem., 52, 223-261 (1983).
14. Palinski W., Rosenfeld M. E., Yla-Herttuala S., Gertner C. G., Socher S. S., Butler S. W., Parthasarathy S., Carew T. E., Steinberg D., Proc. Natl. Acad. Sci. U.S.A., 86, 1372-1376 (1989).
15. Chait A., Eur Heart J., Suppl. E, 15-22 (1987).
16. Haberland M. E., Fogelman A. M., Am. Heart J., 113, 573-577 (1987).
17. Brown M. S., Ho Y. K., Goldstein J. L., J. Biol. Chem., 255, 9344-9352 (1980).
18. Heider J. G., Pickens C. E., Kelly L. A., J. Lipid Res., 24, 1127-1134 (1994).
19. Carr T. P., Hamilton R. L. Jr., Rudel L. L., J. Lipid Res., 36, 25-36 (1995).
20. Huff M. W., Telford D. E., Barrett P. H. R., Billiheimer J. T., Gillies P. J., Arterioscler. Thromb., 14, 1498-1508 (1994).
21. Suckling K. E., Stange E. F., J. Lipid Res., 26, 647-671 (1985).
22. Dallongeville J., Davignon J., Lussier-Cacan S., Metabolism. 41, 154-159 (1992).
23. Faggiotto A., Ross R., Arteriosclerosis, 4, 341-356 (1984).
24. Bell F. D., Schaub R. G., Atherosclerosis, 6, 42-49 (1986).
25. Sliskovic D. R., White A. D., Trends in Pharmacol. Sci., 12, 194-199 (1991).
26. Tabas I., Boycow G. C., Tall A. R., J Clin. Invest., 79, 418-426 (1987).
27. Havel R., Eder H., Bradgon J., Clin. Invest., 34, 1345-1353 (1955).
28. Uchiyama M., Mihara M., Anal. Biochem., 86, 271-278 (1978).
29. Kinnunen P. M., DeMichele A., Lange L., Biochemistry, 27, 7344-7350 (1988).
30. Morisaki N., Matsuoka N., Shirai K., Sato Y., Kumagai A., Atherosclerosis, 37, 439-447 (1980).
31. Heider J. G., Pickens C. E., Kelly L. A., J. Lipid Res., 24, 1127-1134 (1983).
32. Krause B. R., Hoefle M. L., Holmes A., Roth B. D., Keift K. A., Uhlendorf P. D., Steinfield R. L., Sekerke C. S., Bocan T. M. A., Newton R. S., Abstracts of Papers, Drugs Affecting Lipid Metabolism X, Houston, 26, 63 (1989).
33. Krause B. R., Kieft K. A., Stanfield R. L., Bousley R. F., Bisgaier C. L., Circulation, 84 (suppl. 2), 138 (1991).
34. Hinsbergh V. W. M., Atherosclerosis, 53, 113-118 (1984).
35. Parthasarathy S., J Clin. Invest., 89, 1618-1621 (1992).
36. Yla-Hertlula S., Proc. Natl Acad Sci U.S.A., 87, 6959 -6963 (1990).
37. Cathcart M. K., McNally A. K., Chisolm G. M., J. Lipid Res., 32, 63-70 (1991).
38. Heinecke J. W., Baker L., Rosen H., Chait A., J. Clin. Invest., 74, 1890-1894.
39. Sparrow C. P., Olszewski J., J. Lipid Res., 34, 1219-1228 (1993).
40. Kleinveld H. A., Demacker P. N., Stalenhoef A. F., Arterioscler. Thromb., 14, 1386-1391 (1994).
41. Esterbauer H., Puhlm H., Dieber-Rotheneder M., Waeg G., Rabl H., Annals of Medicine, 23, 573-581 (1991).
42. Regenstrom J., Lancet, 339, 1183-1186 (1992).
43. Fancelli D., Chiari A., Cozzi P., Lovisolo P., Severino D., Ghiselli G., J. Enzyme Inhib., 8, 159-172 (1994).